anyone else notice oral GLP-1 kicking in around week 56
Here it is: anyone else notice oral GLP-1 kicking in around week 56. One person, one log, no control group, so read it accordingly. Why "oral" is doing two completely different jobs in the sentences people write here. Oral semaglutide is a peptide co-formulated with an absorption enhancer, which is why it comes with…
do not assume reconstitution intuitions apply, there is nothing to reconstitute
Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one.
Agreed — non-peptide is the fact that everything else follows from, including the manufacturing and the analytics.
Not convinced. Oral semaglutide is a peptide formulated with an absorption enhancer; the comparison you are making does not hold.
a non-peptide agonist does not degrade the way a peptide does